
Vesimycin 2mg Injection
Marketer
Naprod Life Sciences
Salt Composition
Mitomycin (2mg)
Overview Vesimycin 2mg Injection
Pancrea, breast, lung, and stomach cancers may be treated with a 2mg intravenous injection of Vesimycin. This medication, administered solely or as part of combination chemotherapy, inhibits cancerous cell proliferation, leading to their destruction. Always administered intravenously by a physician, self-administration is strictly prohibited. Dosage and frequency are determined by your doctor based on your condition and may vary. Adhere strictly to prescribed instructions; improper use or overdose can cause severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under physician guidance. Common side effects include anemia, leukopenia, increased bleeding risk, anorexia, nausea, and vomiting. Report any concerning symptoms to your doctor; mitigation strategies may be available. Prior to treatment, disclose any blood, kidney, liver, or respiratory conditions. Vesimycin lowers blood cell counts, increasing infection susceptibility. Regular blood tests monitoring blood cells, kidney, liver, and heart function are mandatory. Effective contraception for both partners is crucial throughout treatment to prevent pregnancy.
Uses of Vesimycin 2mg Injection
Cancers of the pancreas, breast, lung (non-small cell type), and stomach.
Major Benefits of Vesimycin 2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Vesimycin 2mg Injection:
- Anemia (low number of red blood cells)
- Decreased white blood cell count
- Increased bleeding tendency
- Loss of appetite
- Nausea
- Vomiting
- Feeling of discomfort
- Low blood platelets
- Weight loss
- Rash
How to use Vesimycin 2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vesimycin 2mg Injection works:
Vesimycin 2mg Injectable Solution is a cancer therapeutic agent. Its mechanism of action involves disrupting the DNA of malignant cells, thereby inhibiting their proliferation and replication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Vesimycin 2mg Injection and alcohol may result in significant sleepiness.
PregnancyUNSAFE
Administration of Vesimycin 2mg Injection is contraindicated in pregnancy. Pregnant individuals should consult a physician, as research in animal models and pregnant women has revealed substantial adverse effects on fetal development.
Breast feedingCAUTION
Administering Vesimycin 2mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Vesimycin 2mg Injection may result in adverse reactions that compromise driving capabilities. These reactions, including nausea and vomiting, can significantly slow response times, rendering safe vehicle operation impossible.
KidneyCAUTION
Patients with impaired kidney function should receive Vesimycin 2mg Injection with careful monitoring; dosage modification may be necessary. Consultation with a physician is advised. Vesimycin 2mg Injection is contraindicated in individuals with terminal kidney failure.
LiverCAUTION
Individuals with liver impairment should use Vesimycin 2mg Injection cautiously, as dose modification may be necessary. Consult a physician before use; prescription may be inadvisable for certain patients with hepatic dysfunction.
What if you forget to take Vesimycin 2mg Injection :
NA
Facts to Know About Vesimycin 2mg Injection
| Label | Value |
|---|---|
| Chemical Type | Cancer-Fighting Antibiotics |
| Developing Habits | No. |
| Type of Treatment | Cancer Medications |
| Actions | Cytotoxic alkaloids |
